Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
Conditions
Interventions
Intervention1: Olanzapine: Tab Olanzapine (2.5mg) will be given to intervention arm from start of treatment to the completion of treatment (8 weeks) to prevent Cancer Cachexia Anorexia Syndrome
Contro
Sponsors
ABHISHEK BASU
Eligibility
Inclusion criteria
Inclusion criteria: Patient should be treatment naive, Eastern Cooperative Oncology Group Perfomance Status scale (ECOG PS) should be between 0-2, FIGO STAGE (2021) 1-4, NO MAJOR LIFE THREATENING COMORBODITIES, BASELINE NORMAL BLOOD PARAMETERS
Exclusion criteria
Exclusion criteria: PATIENTS ON LONG TERM STEROIDS, Patients with PSYCHIATRIC ILLNESS, DENIAL OF CONSENT, PATIENTS WITH METABOLIC SYNDROME, PREGANCY AND LACTATION PATIENTS, BMI LESS THAN 18.5
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the Weight and Appetite change in both the arms at the completion of treatmentTimepoint: At the baseline, at 3rd week and at the end of 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess overal quality of life at the end of treatment in both the armsTimepoint: AT baseline, at 3rd week & at the end of 8 weeks | — |
Countries
India
Contacts
Public ContactAbhishek Basu
Burdwan Medical College and Hospital
Outcome results
None listed